Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Conquering Resistance in HER2-Targeted Breast Cancer Therapies
HER2-positive breast cancer represents a subtype characterized by overexpression of the human epidermal growth factor receptor 2 (HER2), which drives aggressive tumor growth and poorer prognosis. Targeted therapies such as HER2-directed monoclonal antibodies (trastuzumab, pertuzumab) and tyrosine kinase inhibitors (lapatinib,neratinib) have transfo... Read More»
: Breast Can Curr Res
Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article
Make the best use of Scientific Research and information from our 700 + peer reviewed, 黑料网 Journals